Deciphering the antidiabetic potential of Eugenia uniflora L. leaf via α-amylase and α-glucosidase inhibition
Planta Medica · 01.03.2026 · 92 (03) · 341
DOI: 10.1055/s-0045-1815248 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.03.2026. Verfasst von A O Oriola und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Eugenia uniflora L. leaf (EUL) is implicated in the African traditional medicine as a remedy for diabetes, obesity and other metabolic diseases without much scientific knowledge of it therapeutic action and active ingredients [ 1 ]. This study evaluated the antidiabetic potential of EUL by isolating its putative α-amylase and α-glucosidase inhibitors. The EtOH-H20 (80:20) extract was solvent-partitioned into n-hexane, DCM, EtOAc, and n-BuOH fractioned. A bioassay-guided chromatographic fractionation of the most active EtOAc fraction led to isolation of two compounds. The structure elucidation of the compounds were assisted by 1D- and 2D NMR spectroscopy as well as high-resolution mass spectrometry, affording flavone glycosides, namely: Myricetin-3-O-rhamnoside (1); and its isomer described as Unifloratrin (2). The extract, EtOAc fraction, 1 and 2 exhibited IC 50 values of 67.1±2.5, 49.4±2.9, 25.6±1.8 and 33.0±2.2 μM against α-amylase enzyme, suggesting that fractionation has enhanced the bioactivity of the plant. Similarly, 1 demonstrated notable inhibition against α-glucosidase (IC 50 =19.3±2.6 μM), which was less effective to the Metformin standard drug (11.5±1.5 μM) but comparable to Acarbose (17.1±1.3 μM). It can be concluded that EUL actually contains α-amylase and α-glucosidase inhibitors that may help to modulate postprandial blood glucose elevations in diabetic conditions. The study findings also validate the ethnomedicinal claim of EUL as a remedy for diabetes and other metabolic ailments. Publication History Article published online: 05 March 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Oriola, A. O., Kar, P., & Oyedeji, A. O. (2026). Deciphering the antidiabetic potential of Eugenia uniflora L. leaf via α-amylase and α-glucosidase inhibition. Planta Medica, 92(03), 341. https://doi.org/10.1055/s-0045-1815248
Vancouver
Oriola AO, Kar P, Oyedeji AO. Deciphering the antidiabetic potential of Eugenia uniflora L. leaf via α-amylase and α-glucosidase inhibition. Planta Medica. 2026;92(03):341. doi:10.1055/s-0045-1815248
BibTeX
@article{Oriola2026,
author = {Oriola, A O and Kar, P and Oyedeji, A O},
title = {Deciphering the antidiabetic potential of Eugenia uniflora L. leaf via α-amylase and α-glucosidase inhibition},
journal = {Planta Medica},
year = {2026},
volume = {92},
number = {03},
pages = {341},
doi = {10.1055/s-0045-1815248}
}
EUVIMED